Stereotaxis (company)

Stereotaxis, Inc. is a medical technology company based in St. Louis, Missouri. It designs, manufactures, and markets robotic systems and related accessories used in interventional cardiology and electrophysiology procedures. The Stereotaxis system is intended to enhance the precision and safety of catheter-based procedures by providing remote navigation of magnetic catheters within the heart and other parts of the body.

The company's core technology involves the use of magnetic navigation, where external magnets are used to guide a specially designed catheter through blood vessels. This approach allows physicians to remotely control the catheter's movement with greater accuracy and stability compared to manual manipulation.

Stereotaxis technology is used in procedures such as atrial fibrillation ablation, ventricular tachycardia ablation, and other complex cardiac mapping and ablation procedures. The potential benefits of using the Stereotaxis system include reduced radiation exposure for both patients and physicians, improved catheter stability and control, and the ability to access hard-to-reach areas of the heart.

The company's products are sold to hospitals and electrophysiology centers worldwide. Stereotaxis competes with other companies in the electrophysiology market, including those offering traditional manual catheters and other robotic navigation systems. The company continues to develop and refine its technology to improve patient outcomes and expand its market reach.